Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized Rekovelle in IUI
NCT03830723Phase 2Completed
- Sponsor
- clinique ovo
- Start
- Jan 2020
- Primary completion
- Jan 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of recombinant human follicle stimulating hormone in infertility, sponsored by clinique ovo. Primary endpoint: Ovarian response (number of follicles) at 1 year. Started Jan 2020; status: completed.
02
Drugs
recombinant human follicle stimulating hormone
03
Conditions
infertility
Beyond the preview
Go deeper on NCT03830723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03830723.